Adrenal gland disorder, NOS: Difference between revisions
mNo edit summary |
Ttenbergen (talk | contribs) m adding {{Data Integrity Check List}} |
||
| (One intermediate revision by one other user not shown) | |||
| Line 20: | Line 20: | ||
*[[Adrenal gland, benign neoplasm]] | *[[Adrenal gland, benign neoplasm]] | ||
*[[Adrenal gland, primary malignancy]] | *[[Adrenal gland, primary malignancy]] | ||
*[[Hyperadrenal state, NOS]] | |||
*[[Adrenal insufficiency, drug-induced (i.e. due to steroid administration)]] | *[[Adrenal insufficiency, drug-induced (i.e. due to steroid administration)]] | ||
*[[Adrenal insufficiency, primary (Addison's disease)]] | *[[Adrenal insufficiency, primary (Addison's disease)]] | ||
| Line 26: | Line 27: | ||
*[[Endocrine gland NOS, primary malignancy]] | *[[Endocrine gland NOS, primary malignancy]] | ||
*[[Endocrine gland NOS, benign neoplasm]] | *[[Endocrine gland NOS, benign neoplasm]] | ||
*[[Multiple endocrine adenomatosis (multiple endocrine neoplasia syndrome, MEN)]] | |||
*[[Cushing's syndrome, drug-induced]] | |||
*[[Cushing's syndrome, NOS]] | |||
| Line 36: | Line 40: | ||
== Related CCI Codes == | == Related CCI Codes == | ||
{{Data Integrity Check List}} | |||
== Related Articles == | == Related Articles == | ||
{{Related Articles}} | {{Related Articles}} | ||
{{ICD10 footer}} | {{ICD10 footer}} | ||
{{EndPlaceHolder}} | {{EndPlaceHolder}} | ||